Vanessa S. K.
- Country
- Austria
- Department
- Department of Internal Medicine
Research Overview
- N1T-MC-MALO: A Master Protocol for a Randomized, Controlled, Clinical Trial of Multiple Pharmacologic Agents in Adult Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease Who Are at Increased Risk of Developing Major Adverse Liver Outcomes (SYNERGY-Outcomes); N1T-MC-TZ01 Tirzepatide in participants with high-risk MASLD; N1T-MC-RT01 Retatrutide in participants with high-risk MASLD
- Phase 3 Randomized Double‑Blind Placebo‑Controlled Study of Efimosfermin Alfa in Adults with Biopsy‑Confirmed F2–F3 Metabolic Dysfunction‑Associated Steatohepatitis
- Phase 3 Randomized Double‑Blind Placebo‑Controlled Study of Efimosfermin Alfa Safety and Tolerability in Adults with F2‑F3 Metabolic Dysfunction‑Associated Steatohepatitis
Data & Insights
Has run more than one trial at 112 of 203 partner sites.
Specializations
Hepatology Research
Specialized in studying and treating non-alcoholic steatohepatitis (NASH), focusing on innovative therapeutic approaches for liver disease management.
- Liver Disease Progression
- Hepatic Fibrosis
- Metabolic Liver Conditions
Investigates advanced treatments targeting liver histology improvement and prevention of liver-related clinical events.
Metabolic Disorders
Conducts research in the field of metabolic health conditions, with particular emphasis on liver manifestations of metabolic syndrome.
- Metabolic Syndrome
- Fatty Liver Disease
- Hepatic Steatosis
Explores therapeutic interventions for metabolic liver disorders using innovative treatment approaches.
Clinical Therapeutics
Focuses on evaluating therapeutic interventions for chronic liver conditions, specifically investigating treatments for advanced liver fibrosis.
- Liver Fibrosis Treatment
- Disease Modification
- Clinical Outcomes
Evaluates novel therapeutic agents for improving liver health and preventing disease progression.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.